{"rows":[{"id":4275,"title":"Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders","authors":"M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali","journal":"Journal of Pharma Insights and Research.","publication_date":"2025-10-05","publication_year":2025,"doi":"10.69613/thv1dn30","pubmed_id":null,"openalex_id":"https://openalex.org/W4416779935","source_url":"https://doi.org/10.69613/thv1dn30","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-08-09 08:25:16","bibtex":null,"source_record_id":"DOI:10.69613/thv1dn30","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.69613/thv1dn30","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.69613/thv1dn30","source_url":"https://doi.org/10.69613/thv1dn30","doi":"10.69613/thv1dn30","pmid":"","publication_date":"2025-10-05","importer_version":"2.1.3","text_redistributed":false}}],"total":1,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Journal of Pharma Insights and Research.","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}